Response to Letter by Gonzalez-Hernandez et al

To the Editor: We thank Gonzalez-Hernandez et al for their interest in our article.1 Firstly, we acknowledge that treatments similar to FASTER2/EXPRESS were initiated quickly in this population, which may have contributed to the low incidence of recurrence in the first few days. …